Xeris Pharmaceuticals | XERS - Marktkapitalisierung

Aktienkurs
6.38
Täglich Wechseln
-0.06 -0.86%
Monatlich
2.82%
Jährlich
33.09%
Q2 Prognose
6.39




Marktkapitalisierung Veränderung Datum
Celltrion KRW 42.71T 908.1B 2026-05
Cspc Pharmaceutical CNY 87.29B 19.74B 2025-12
Deva Holding AS TRY 17.54B 7.76B 2023-09
Dianthus Therapeutics USD 1.78B 215M 2025-12
Divis Laboratories Ltd INR 1.7T 186.62B 2025-12
Eli Lilly USD 869.02B 146.97B 2026-03
Kangmei Pharma CNY 27.93B 1.73B 2025-09
Knight Therapeutics CAD 600.53M 14.56M 2025-12
Laboratorios Farma EUR 4.17B 917.16M 2026-03
Malin Corporation EUR 142.92M 19.65M 2026-02
Medical Developments International AUD 62.53M 563.29K 2025-12
Nektar Therapeutics USD 15.62B 14.76B 2026-05
Neuren Pharmaceuticals AUD 2.36B 606.56M 2025-12
Organigram Holdings CAD 312.16M 66.64M 2025-12
Ovoca Bio EUR 6.12M 4.93M 2026-04
Pacira USD 915M 149M 2026-03
Perrigo USD 1.58B 265M 2026-05
Pharma Mar EUR 1.71B 141.4M 2026-05
Qiagen NV USD 6.43B 1.85B 2026-05
Sartorius EUR 14.25B 2.16B 2026-03
Supernus Pharmaceuticals USD 2.82B 155M 2026-05
Zealand Pharma A/S 33.35B 448.34M 2025-12